With 75091.0 shares changed hands, the volume of the stock remained lighter than its average volume of 81550.0 shares. During the session, the Medical Devices company that operates in wider Healthcare sector, reached to the highest price of $20.83 whereas the lowest price it dropped to was $20.12. The 52-week range on ELMD shows that it touched its highest point at $35.56 and its lowest point at $13.74 during that stretch. It currently has a 1-year price target of $34.33. Beta for the stock currently stands at 0.40.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of ELMD was down-trending over the past week, with a drop of -4.11%, but this was up by 1.46% over a month. Three-month performance dropped to -13.95% while six-month performance fell -31.10%. The stock lost -29.68% in the past year, while it has gained 46.86% so far this year. A look at the trailing 12-month EPS for ELMD yields 0.80 with Next year EPS estimates of 0.96. For the next quarter, that number is 0.21. This implies an EPS growth rate of 40.80% for this year and 17.14% for next year. EPS is expected to grow by 22.65% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of 20.42%.
Float and Shares Shorts:
At present, 8.51 million ELMD shares are outstanding with a float of 6.62 million shares on hand for trading. On 2025-06-13, short shares totaled 0.15 million, which was 179.0 higher than short shares on 1747267200. In addition to Mr. James L. Cunniff as the firm’s President, CEO & Director, Mr. Bradley M. Nagel serves as its CFO, Treasurer & Secretary.
Institutional Ownership:
Through their ownership of 0.50753 of ELMD’s outstanding shares, institutional investors have minority control over the company.
An Overview of Recent Financials:
Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on 2025-03-31, ELMD reported revenue of $15684000.0 and operating income of $2140000.0. The EBITDA in the recently reported quarter was $2423000.0 and diluted EPS was $0.21.
Analysts Ratings:
In the same way, a target price assigned to a stock can also reveal much about its potential. With ELMD analysts setting a high price target of 38.0 and a low target of 38.0, the average target price over the next 12 months is 38.0. Based on these targets, ELMD could surge 82.87% to reach the target high and rise by 82.87% to reach the target low. Reaching the average price target will result in a growth of 82.87% from current levels.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of $0.51 being high and $0.51 being low. For ELMD, this leads to a yearly average estimate of $0.51.
